Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas.
Goschzik T, Mynarek M, Doerner E, Schenk A, Spier I, Warmuth-Metz M, Bison B, Obrecht D, Struve N, Kortmann RD, Schmid M, Aretz S, Rutkowski S, Pietsch T.
Goschzik T, et al. Among authors: schenk a.
Acta Neuropathol. 2022 Dec;144(6):1143-1156. doi: 10.1007/s00401-022-02505-5. Epub 2022 Oct 1.
Acta Neuropathol. 2022.
PMID: 36181537
Free PMC article.